Literature DB >> 23098824

Measles outbreak in Andalusia, Spain, January to August 2011.

Jm Mayoral Cortes1, E Perez Morilla, V Gallardo Garcia, Jm Navarro Mari, M Perez Ruiz, R Hermosilla, J Diaz-Borrego, E Rodriguez Romero, J Ruiz Fernandez.   

Abstract

On 7 January 2011, a six year-old child living in a Roma community near Seville, southern Spain, was hospitalised with measles. Contact tracing identified a probable index case with onset of symptoms on 20 December 2011 and several unreported cases among children under the age of 15 years in the same town. The outbreak initially spread in districts in the city of Seville with a high proportion of Roma residents, and later to other cities and towns in Andalusia. While some towns experienced wide spread of the disease with significant clusters of cases, most of the affected locations saw non-clustered cases or very few secondary cases. The outbreak resulted in 1,759 confirmed or probable cases of which 393 (19%) required hospitalisation. Measles virus of genotype D4 was diagnosed in more than half of the cases. Significant differences (p<0.0001) by age group were found between clustered and non-clustered cases. The highest proportion of clustered cases occurred in the age group of 5-14 yearolds, while the highest proportion of non-clustered cases was seen in those older than 29 years. The last confirmed case related to this outbreak was reported on 20 August 2011.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23098824

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


  8 in total

1.  Comparative evaluation of a new chemiluminiscent assay and an ELISA for the detection of IgM against measles.

Authors:  Antonio Sampedro; Javier Rodríguez-Granger; Cristina Gómez; Ana Lara; José Gutierrez; Ana Otero
Journal:  J Clin Lab Anal       Date:  2013-11       Impact factor: 2.352

2.  Sustained outbreak of measles in New South Wales, 2012: risks for measles elimination in Australia.

Authors:  Zeina Najjar; Kirsty Hope; Penelope Clark; Oanh Nguyen; Alexander Rosewell; Stephen Conaty
Journal:  Western Pac Surveill Response J       Date:  2015-01-30

3.  Vaccination campaign at a temporary camp for victims of the earthquake in Lorca (Spain).

Authors:  Jaime Jesús Pérez-Martín; Francisco José Romera Guirado; Yolanda Molina-Salas; Pedro José Bernal-González; José Antonio Navarro-Alonso
Journal:  Hum Vaccin Immunother       Date:  2017-03-31       Impact factor: 3.452

Review 4.  Paget's disease of bone-genetic and environmental factors.

Authors:  Frederick R Singer
Journal:  Nat Rev Endocrinol       Date:  2015-08-18       Impact factor: 43.330

5.  Time trends in pediatric hospitalizations for hepatitis A in Greece (1999-2013): Assessment of the impact of universal infant immunization in 2008.

Authors:  V Papaevangelou; Z Alexopoulou; C Hadjichristodoulou; G Kourlamba; A Katsioulis; K Theodoridou; V Spoulou; M Theodoridou
Journal:  Hum Vaccin Immunother       Date:  2016-05-04       Impact factor: 3.452

6.  Considerations on the current universal vaccination policy against hepatitis A in Greece after recent outbreaks.

Authors:  Kassiani Mellou; Theologia Sideroglou; Vassiliki Papaevangelou; Anna Katsiaflaka; Nikolaos Bitsolas; Eleni Verykouki; Eleni Triantafillou; Agoritsa Baka; Theano Georgakopoulou; Christos Hadjichristodoulou
Journal:  PLoS One       Date:  2015-01-15       Impact factor: 3.240

7.  Measles outbreak in Macedonia: epidemiological, clinical and laboratory findings and identification of susceptible cohorts.

Authors:  Irena T Kondova; Zvonko Milenkovic; Sanja P Marinkovic; Golubinka Bosevska; Gordana Kuzmanovska; Goran Kondov; Sonja Alabakovska; Claude P Muller; Judith M Hübschen
Journal:  PLoS One       Date:  2013-09-10       Impact factor: 3.240

Review 8.  Under-vaccinated groups in Europe and their beliefs, attitudes and reasons for non-vaccination; two systematic reviews.

Authors:  N Fournet; L Mollema; W L Ruijs; I A Harmsen; F Keck; J Y Durand; M P Cunha; M Wamsiedel; R Reis; J French; E G Smit; A Kitching; J E van Steenbergen
Journal:  BMC Public Health       Date:  2018-01-30       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.